Get in touch

Tiefenbacher first-to-market launch: Rivaroxaban

Tiefenbacher Group - A smiling older couple embraces outdoors in a garden, looking happy and relaxed. The man wears a blue shirt; the woman, a light pink top. The "Tiefenbacher Pharmaceuticals" logo highlights their family-owned pharmaceutical company in the upper left corner.

Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.We at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world – irrespective of their nationality or income. That´s why we are thrilled to share that we have successfully prepared a day one launch of the generic version of Rivaroxaban.   […]

Tiefenbacher New Market Launch: Rivaroxaban in Canada

Tiefenbacher Group - A smiling older woman with short gray hair joyfully gives a piggyback ride to a laughing older man outdoors, highlighting Tiefenbacher Pharmaceuticals' commitment to generic medicines manufacturing. The company logo is in the top left corner.

Tiefenbacher Pharmaceuticals successfully launches the anticoagulant Rivaroxaban on day one in CanadaWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be affordable and available for all patients around the world. A key point here is that this applies to everyone, regardless of their nationality or income. That´s why we are thrilled to share that […]

Tiefenbacher New Market Launch: generic launch Teriflunomide

Tiefenbacher Group - A smiling woman in a navy raincoat stands on a beach, holding her hood. The AET TIEFENBACHER PHARMACEUTICALS logo appears in the top left, reflecting their focus on patient-centric drug development. The background shows the sea and greenery.

New market launch: Tiefenbacher Pharmaceuticals successfully launches the generic version of Teriflunomide in more than 20 European countriesTiefenbacher Pharmaceuticals has successfully prepared a day one launch of the generic version of the Multiple Sclerosis (MS) medication Teriflunomide (reference brand name: Aubagio). This complex generic launch explicitly follows Tiefenbacher Group`s strategy to make high quality pharmaceuticals […]

State-of-the-art R&D facilities for powerful drug development

Tiefenbacher Group - A large group gathers outdoors under a colorful canopy for a groundbreaking ceremony as a priest leads rituals. Highlighting Tiefenbacher Group’s family-owned pharmaceutical company and patient-centric drug development, event details frame the image.

State-of-the-art R&D facilities for powerful drug development and manufacturing. New technology for generic, valued added, and innovative pharmaceuticalsWe, at Tiefenbacher Group, go beyond R&D and manufacturing of pharmaceuticals with a commitment to quality, safety, and reliability that is anchored in everything we do. We continuously expand in novel technologies and capabilities to improve quality and […]

Tiefenbacher Generic Launch: antihistamine Bilastine

Tiefenbacher Group - A smiling young man in a blue shirt lies on his back in green grass with his hands behind his head, reflecting the patient-centric drug development focus of Tiefenbacher Pharmaceuticals. The company’s logo appears in the top left corner.

Generic Launch: Tiefenbacher Pharmaceuticals successfully launches the antihistamine Bilastine for a market entry as over-the-counter (OTC) medicine in germanyGeneric drugs: As the allergy season is starting, we at Tiefenbacher Pharmaceuticals are thrilled to announce that we have successfully prepared the launch of the antihistamine Bilastine for a market entry as Over-the-counter (OTC) medicine in Germany. […]

Tiefenbacher Pharmaceuticals New Market Launch: Vildagliptin/Metformin

Tiefenbacher Group - Two older women smiling and hugging outdoors, both appearing joyful. The logo and text “AET TIEFENBACHER PHARMACEUTICALS” is visible in the top left corner, highlighting patient-centric drug development.

NEW Market Launch: TIEFENBACHER PHARMACEUTICALS successfully launches generic version of the diabetes medicine Vildagliptin and Vildagliptin /Metformin in AfricaWe at Tiefenbacher Pharmaceuticals strive to make our high-quality medicines available and affordable to as many people as possible around the world. Therefore Tiefenbacher Group is happy to share that we have successfully prepared the launch of […]

Tiefenbacher Pharmaceuticals New Market Launch: Rivaroxaban

Tiefenbacher Group - A young man and an older man in patterned shirts and a hat smile together outdoors. The AET Tiefenbacher Pharmaceuticals logo appears in the top left corner, highlighting expertise in pharmaceutical healthcare solutions.

Global market launch: TIEFENBACHER PHARMACEUTICALS expands the launch of the anticoagulant medicine Rivaroxaban to Central America and further international marketsWe at Tiefenbacher Pharmaceuticals strongly believe that our high-quality medicines should be available for all patients around the world – irrespective of their origin or nationality. That´s why we are happy to share that we have successfully […]

TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus

Tiefenbacher Group - A collage showcases Tiefenbacher Group facilities, highlighting modern glass-fronted offices, industrial buildings, manufacturing equipment, and the Tiefenbacher Group logo, reflecting their commitment to patient-centric drug development and pharmaceutical healthcare solutions.

Driving efficiency is our key – TIEFENBACHER GROUP enlarges its manufacturing facilities in India and Cyprus for powerful drug productionDid you know that TIEFENBACHER GROUP heavily invests in its own manufacturing facilities to secure an efficient and reliable supply of our high-quality pharmaceuticals for patients around the world? As fully integrated pharmaceutical company, we offer […]

TIEFENBACHER PHARMACEUTICALS: Launch of generic version of Teriflunomide, Multiple Sclerosis (MS)

Tiefenbacher Group - A group of five older adults, three men and two women, stand close together outdoors, smiling and laughing under leafy trees on a sunny day, reflecting the joy that patient-centric drug development brings to thriving communities in a lush park setting.

TIEFENBACHER PHARMACEUTICALS announces global generic launch of Teriflunomide – making multiple sclerosis therapy more affordable and better available worldwideTiefenbacher Pharmaceuticals has successfully developed a global dossier for a generic version of Teriflunomide 7 mg and 14 mgfilm-coated tablets. Generics are therapeutically equivalent to their branded counterparts with a lower price due to losing patent protection. Teriflunomide […]

TIEFENBACHER PHARMACEUTICALS: Launch of Rivaroxaban

Tiefenbacher Group - Blister packs of white pills and capsules are arranged on a white surface, overlaid with translucent blue hexagons and digital interface elements, reflecting patient-centric drug development by a family-owned pharmaceutical company.

TIEFENBACHER PHARMACEUTICALS announces global launch of Rivaroxaban – an anticoagulant medication (blood thinner)Tiefenbacher Pharmaceuticals, part of Tiefenbacher Group, is pleased to announce the availability of a registration dossier for the generic of Rivaroxaban 2.5 mg, 10 mg, 15 mg and 20 mg film-coated tablets. Generics are therapeutically equivalent to their branded counterparts with a lower […]

International Brand Relaunch of Tiefenbacher Group

Tiefenbacher Group - A man in a dark suit and glasses sits on a chair by a large window overlooking modern office buildings and a waterfront. He is smiling, has short, light hair, and projects the professionalism of a family-owned pharmaceutical company.

Tiefenbacher Group: Improving people’s life by making pharmaceuticals more affordable, more available, and better than before”We are very excited to launch the new Tiefenbacher Group website. It represents the fundamental changes which we have started in the recent years. We are on the move to drive important efficiencies in our supply chain and become a […]

Get in touch